Injection-site residues

Current effective version

PDF iconAdopted guideline

Reference numberEMEA/CVMP/542/2003
Effective from13/04/2005
KeywordsInjection site residues, consumer safety, withdrawal periods
DescriptionThis document addresses the assessment of potential consumer risk from veterinary drug residues remaining at intramuscular and subcutaneous injection sites and the elaboration of appropriate pre-slaughter withdrawal periods.

Document history

First version

Current version

PDF iconAdopted guideline


PDF iconOverview of comments

In operation: 13/04/2005–present


Published: 13/01/2005

Related content

How useful was this page?

Add your rating